|
Volumn 11, Issue 9, 1993, Pages 1629-1635
|
Modulation of multidrug resistance: At the threshold
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE;
CARBOPLATIN;
CARMUSTINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
CYCLOSPORIN D;
CYTARABINE;
CYTOTOXIC AGENT;
DACTINOMYCIN;
DAUNORUBICIN;
DNA TOPOISOMERASE (ATP HYDROLYSING);
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
GLYCOPROTEIN P;
IDARUBICIN;
LORAZEPAM;
METHOTREXATE;
MITOXANTRONE;
NAVELBINE;
PACLITAXEL;
QUINIDINE;
TAMOXIFEN;
TENIPOSIDE;
UNINDEXED DRUG;
VERAPAMIL;
VINBLASTINE;
VINCRISTINE;
ACUTE GRANULOCYTIC LEUKEMIA;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER RESISTANCE;
COLORECTAL CANCER;
CROSS RESISTANCE;
DIGESTIVE SYSTEM FUNCTION DISORDER;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
EDITORIAL;
GENE EXPRESSION REGULATION;
HEART BLOCK;
HUMAN;
MULTIDRUG RESISTANCE;
NAUSEA;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
VOMITING;
|
EID: 0027165416
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.1993.11.9.1629 Document Type: Editorial |
Times cited : (204)
|
References (0)
|